Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share (ABOS)

27 filings reported holding ABOS - Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share as of Q1 2024.
Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share (ABOS) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1.31M shares of 60.7M outstanding shares and own 2.17% of the company stock.
Largest 10 shareholders include JANE STREET GROUP, LLC (600K shares), Ikarian Capital, LLC (266K shares), Squarepoint Ops LLC (113K shares), CATALYST FINANCIAL PARTNERS LLC (89.7K shares), JPMORGAN CHASE & CO (71.9K shares), Brevan Howard Capital Management LP (56.4K shares), MORGAN STANLEY (48.7K shares), Point72 Asia (Singapore) Pte. Ltd. (27.6K shares), CITADEL ADVISORS LLC (23.4K shares), and Chicago Partners Investment Group LLC (14K shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.